The adjusted rate of opioid use increased nearly 4-fold (adjusted odds ratio, 4.18; 95% CI, 1.76-9.96), from 4.7% among new immigrants to 14.8% among those who had been in this country for 15 years or more.
From 2015 to 2017, number of opioid-involved overdose deaths increased for nearly all racial/ethnic groups.
A newly established center at Johns Hopkins is reinvigorating research on the potential therapeutic applications of psychedelics.
Investigators extracted data from 8 waves of the Monitoring the Future study, which annually surveyed approximately 17,000 US high school students starting in 1975.
The Canadian Research Initiative in Substance Misuse National Injectable Opioid Agonist Treatment Steering Committee has released a new guideline.
There is enormous need for well-trained providers who are educated in treating opioid use disorder.
The authors suggest that removing X-waiver requirements would allow healthcare providers to better assist patients with opioid use disorder.
Opioid deaths decreased during January to July 2018, while deaths from illicitly manufactured fentanyl (IMF) increased during the same period.
More than 60% of young adults who reported nonmedical prescription opioid use in the previous 30 days screened positive for depressive symptomology using the Center for Epidemiologic Studies Short Depression Scale.
OxyContin maker Purdue Pharma has reached a tentative settlement with a coalition of states and local governments that sued the company over its role in America’s ongoing opioid crisis.
